The P53 gene;Le gène p53

Progres en Urologie

Volumn 15, Issue 6 SUPPL. 1, 2005, Pages 1338-1343

  Chopin, Dominique ^a   Cappellen, D ^a   Fradvanyi, François ^a   Gattegno, Bernard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER TUMOR; GENETICS; HUMAN; PHYSIOLOGY; REVIEW; TUMOR SUPPRESSOR GENE;

GENES, P53; HUMANS; URINARY BLADDER NEOPLASMS;

EID: 33749070840     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. CORDON-CARDO, C., DALBAGNI, G., SAEZ, G. T., OLIVA, M. R., ZHANG, Z. F., ROSAI, J., REUTER, V. E., AND PELLICER, A. p53 mutations in human bladder cancer: genotypic versus phenotypic patterns. Int J Cancer, 56: 347-353, 1994.
2. VET, J. A., BRINGUIER, P. P., SCHAAFSMA, H. E., WITJES, J. A., DEBRUYNE, F. M., AND SCHALKEN, J. A. Comparison of P53 protein overexpression with P53 mutation in bladder cancer: clinical and biologic aspects. Lab Invest, 73: 837-843, 1995.
3. POPOV, Z., HOZNEK, A., COLOMBEL, M., BASTUJI-GARIN, S., LEFRERE-BELDA, M. A., BELLOT, J., ABBOH, C. C., MAZEROLLES, C., AND CHOPIN, D. K. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder. Cancer, 80: 1472-1481, 1997.
4. WARREN, W., BIGGS, P. J., EL-BAZ, M., GHONEIM, M. A., STRATTON, M. R., AND VENITT, S. Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours. Carcinogenesis, 16: 1181-1189, 1995.
5. MOORE, L. E., SMITH, A. H., ENG, C., DEVRIES, S., KALMAN, D., BHARGAVA, V, CHEW, K., FERRECCIO, C., REY, O. A., HOPENHAYN, C., BIGGS, M. L., BATES, M. N., and Waldman, F. M. P53 alterations in bladder tumors from arsenic and tobacco exposed patients. Carcinogenesis, 24: 1785-1791, 2003.
6. ESRIG, D., SPRUCK, C. H., 3RD, NICHOLS, P. W., CHAIWUN, B., STEVEN, K., GROSHEN, S., CHEN, S. C., SKINNER, D. G., JONES, P. A., AND COTE, R. J. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol, 143: 1389-1397, 1993.
7. LACOMBE, L., DALBAGNI, G., ZHANG, Z. F., CORDON-CARDO, C., FAIR, W. R., HERR, H. W., AND REUTER, V. E. Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guerin therapy: correlation to clinical outcome. J Clin Oncol, 14: 2646-2652, 1996.
8. POPOV, Z., HOZNEK, A., COLOMBEL, M., BASTUJI, S., ABBOU, C. C., AND CHOPIN, D. K. [Evaluations of protein p53 overexpression in cancer of the bladder: prognostic value]. Chirurgie, 121: 461-469, 1996.
9. SIDRANSKY, D., VON ESCHENBACH, A., TSAI, Y. C., JONES, P., SUMMERHAYES, I., MARSHALL, F., PAUL, M., GREEN, P., Hamilton, S. R., Frost, P., and et al. Identification of p53 gene mutations in bladder cancers and urine samples. Science, 252: 706-709, 1991.
10. SIDRANSKY D. AND MESSING, E. Molecular genetics and biochemical mechanisms in bladder cancer. Oncogenes, tumor suppressor genes, and growth factors. Urol Clin North Am, 19: 629-639, 1992.
11. VET, J. A., WITJES, J. A., MARRAS, S.A., HESSELS, D., VAN DER POEL, H. G., DEBRUYNE, F. M., AND SCHALKEN, J. A. Predictive value of p53 mutations analyzed in bladder washings for progression of high-risk superficial bladder cancer. Clin Cancer Res, 2: 1055-1061, 1996.
12. MCSHANE, L. M., AAMODT, R., CORDON-CARDO, C., COTE, R., FARAGGI, D., FRADET, Y., GROSSMAN, H. B., PENG, A., TAUBE, S. E., AND WALDMAN, F. M. Reproducibility of p53 immunohistochemistry in bladder tumors. National Cancer Institute, Bladder Tumor Marker Network. Clin Cancer Res, 6: 1854-1864, 2000.
13. CHOPIN, D. [p53 and prognosis of urothelial bladder tumors]. Pathol Biol (Paris), 45: 893-897, 1997.